The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change+30.2% to $128.00
Predicted High$128.00at 6 months
Predicted Low$95.00at 1 month
Max Drawdown (predicted)-3.3%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Sep 11, 2026 1:01 pm
Bull
NICE trends higher to
$128.00
(+30.2% from $98.29)
by Mar 2027.
dip-then-recover
ThesisNICE trades deeply below multiple fair-value anchors with a strong earnings track record, but a risk-off regime and negative sentiment cap near-term upside. Expect a shallow drift lower or sideways early, then gradual mean-reversion toward value as sentiment stabilizes and quality reasserts, though full convergence to $170+ within 6 months is unlikely.
Invalidated ifBreak below $88 on heavy volume or an earnings miss would falsify the recovery thesis; sustained move above $125 accelerates it.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $98.29 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Sep 11, 2026
—
$98.29at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Sep 25, 2026
$89.08–$107.50typical range · internal point $96.50
—
±9.4%
6/10
risk-off tape and negative sentiment press near term
What actually happened:
closed $113.63
on Sep 24, 2026 = +15.6% vs the call
(predicted -1.8%)
· direction MISS
(called flat, was up)
· off by 17.4 pp
· accuracy 4/10
· typical range ±9.4%:
OUTSIDE the band
· S&P +0.6%
over the same window — lagged it
1 month
Oct 11, 2026
$84.94–$111.64typical range · internal point $95.00
—
±13.6%
5/10
fallen-angel narrative persists, no catalyst yet
2 months
Nov 11, 2026
$101.00
—
+2.8%
5/10
value buyers emerge below $100, earnings approach
3 months
Dec 11, 2026
$108.00
—
+9.9%
5/10
Q4 print likely beats, sixth straight beat
4 months
Jan 11, 2027
$115.00
—
+17.0%
4/10
post-earnings drift, sentiment thaws
5 months
Feb 11, 2027
$122.00
—
+24.1%
4/10
gradual re-rating toward quality and value
6 months
Mar 11, 2027
$128.00
—
+30.2%
3/10
partial convergence toward fair value anchors
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$170.33
(+73.3%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.